Publications by authors named "Eric Farbman"

Claim this Profile
H
Hope vs Hype III: Should physicians be more open in endorsing cannabis for Parkinson's disease?
Eric Farbman, Saar Anis, Diego Torres-Russotto

Parkinsonism Relat Disord· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's Disease.
Connie Marras, Kelly A Mills, Shirley Eberly, David Oakes, Kelvin L Chou, Eric S Farbman

Mov Disord· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease.
Eric S Farbman, Cheryl H Waters, Peter A LeWitt, Monika Rudzińska, Michael Klingler

Parkinsonism Relat Disord· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease.
James Tetrud, Paul Nausieda, David Kreitzman, Grace S Liang, Anette Nieves, Eric S Farbman

J Neurol Sci· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
Andrew McGarry, Michael McDermott, Karl Kieburtz, Elisabeth A de Blieck, Flint Beal, Eric S Farbman

Neurology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

JAMA· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The case for subspecialization in neurology: movement disorders.
Eric S Farbman

Front Neurol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis